Converting a drug from off‐label to on‐label use: Government subsidies and patient welfare-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Converting a drug from off‐label to on‐label use: Government subsidies and patient welfare

Published:2022-06-20 Issue: Volume: Page:
ISSN:0011-7315
Container-title:Decision Sciences
language:en
Short-container-title:Decision Sciences

Author:

Olsder Wendy¹,Martagan Tugce¹^ORCID,Tang Christopher S.²^ORCID

Affiliation:

1. School of Industrial Engineering Eindhoven University of Technology Eindhoven The Netherlands

2. Anderson School of Business University of California Los Angeles California USA

Publisher

Wiley

Subject

Management of Technology and Innovation,Information Systems and Management,Strategy and Management,General Business, Management and Accounting

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/deci.12574

Reference59 articles.

1. Outcome‐based pricing for new pharmaceuticals via rebates;Adida E.;Management Science,2021

2. Government interventions to promote agricultural innovation;Akkaya D.;Manufacturing & Service Operations Management,2021

3. A comparison of VaR and CVaR constraints on portfolio selection with the mean‐variance model;Alexander G.J.;Management Science,2004

4. Efficient feed‐in‐tariff policies for renewable energy technologies;Alizamir S.;Operations Research,2016

5. An analysis of price vs. revenue protection: government subsidies in the agriculture industry;Alizamir S.;Management Science,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP